Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

No benefit of adding bevacizumab to standard therapy in pancreatic cancer

Jan. 23, 2007

Safety data from the STAR study presented

Jan. 23, 2007

PRX-302 shows promise for prostate cancer

Jan. 23, 2007

Full European approval for Sutent in advanced renal cell carcinoma

Jan. 22, 2007

Alimta launched in Japan for malignant pleural mesothelioma

Jan. 22, 2007

INNO-406 found effective in animal models of CNS Ph+ leukemia

Jan. 22, 2007

Adherex acquires GSK's options to eniluracil

Jan. 22, 2007

Archemix and Merck KGaA sign aptamer agreement in cancer

Jan. 22, 2007

VASTox joins European consortium to research new treatments for cancer

Jan. 22, 2007

Novartis discovers a potent NPM-ALK kinase inhibitor

Jan. 22, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...